Special Issue "Inflammatory Bowel Disease: Clinical Diagnosis and Treatment Guidelines"

A special issue of Medicina (ISSN 1010-660X). This special issue belongs to the section "Public Health".

Deadline for manuscript submissions: 1 February 2021.

Special Issue Editor

Dr. Amosy E M'Koma
Website
Guest Editor
Division of Biomedical Sciences, Meharry Medical College, Nashville, TN, USA
Interests: inflammatory bowel disease; ulcerative colitis (UC); Crohn’s diseases (CD); indeterminate colitis (IC); colorectal surgery; pelvic pouch reconstruction; restorative proctocolectomy (RPC); ileal pouch-anal anastomosis (IPAA); familial adenomatous polyposis (FAP)

Special Issue Information

Dear Colleagues,

This Special Issue of Medicina, “Clinical Diagnosis and Treatment Guidelines”, aims to present recent interesting advances and challenging aspects in research in inflammatory bowel disease (IBD). It is now clear that IDB is increasing worldwide and has become a global emergence. Inflammatory bowel disease, which includes Crohn’s disease (CD) and ulcerative colitis (UC), has been considered a problem in industrial–urbanized societies and attributed largely to Western culture habits, lifestyle, and other environmental factors. Its incidence and prevalence in developing countries is steadily rising, likely as a consequence of the rapid modernization and Westernization of the population. The two main medical sub-types of IBD are believed to have a multifactorial etiopathogenesis, and no drugs are available for their cure. Despite advances in diagnostics and therapeutics modalities, clinicians often painstakingly face the inconclusive diagnosis of “indeterminate colitis” when the diagnostic elements for the identification of the two diseases are insufficient, which hinders the planning of an appropriate treatment and the establishment of a prognosis. This often causes inappropriate surgery, poor treatment outcomes, and unnecessary costs. This Special Issue will present current advances to solve diagnostics challenges and determine correct treatment regimens for IBD and will highlight future research directions in this field.

Dr. Amosy E M'Koma
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Inflammatory bowel disease
  • Crohn’s colitis
  • Ulcerative colitis
  • Indeterminate colitis
  • Molecular diagnostic (IBD)
  • Colitis-associated colorectal cancer
  • Treatment regimens (IBD)
  • Proctocolectomy
  • Restorative
  • Ileal pouch-anal anastomosis
  • Colonic ileal metaplasia (IBD)
  • Biomarkers (IBD)

Published Papers

This special issue is now open for submission.
Back to TopTop